3D Skin Constructs with ECM Scaffold Segmentation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating three-dimensional skin tissue constructs that mimic the basal-to-suprabasal transition in the epidermis are limited by the inability to recreate the fine layers at basal and suprabasal locations, which are critical for understanding diseases like pemphigus vulgaris.
Innovation Solution
A method involving the deposition of droplets containing undifferentiated keratinocyte cells on a substrate, followed by maintaining the cells in a condition that promotes differentiation, allowing for the generation of a basal-to-suprabasal transition in a three-dimensional skin tissue construct.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Shape
If 3D bioprinting is used to produce stratified epithelium, then tissue architecture is recreated in a layer-by-layer fashion, but the fine layers at basal and suprabasal locations cannot be generated due to resolution limitations
Solution Approach 1:
The invention segments the epidermal layers by selectively degrading specific ECM components (collagen IV, laminin, fibronectin) at controlled rates, allowing different layers to form and differentiate at different paces, thereby achieving fine resolution of basal and suprabasal layers that cannot be printed directly
Solution Approach 2:
The invention performs preliminary action by pre-assembling a scaffold with multiple ECM components before cell seeding, and pre-programming their degradation timelines to guide subsequent layer-by-layer epithelial formation and differentiation without requiring high-precision printing of each fine layer
2Stability of the object's composition
If scaffold-based biofabrication methods are used, then 3D tissue structures can be formed, but the degradation rate of supporting matrices must be matched to new tissue formation pace, complicating the process
Solution Approach 1:
The invention changes the degradation parameters of different ECM components independently by selecting materials with inherently different degradation rates (collagen IV slower than fibronectin), allowing the scaffold to progressively transform from a supportive structure to a fully differentiated tissue without manual intervention to match degradation rates
3Ease of operation
If skin organoids are produced by stem cell differentiation, then self-assembled mini organs are created, but precise spatial control is not allowed
Solution Approach 1:
The invention introduces an intermediary ECM scaffold that mediates between the self-organizing cells and the desired spatial architecture, providing spatial cues through controlled degradation that guides cell differentiation and layer formation while maintaining the benefits of self-assembly
Data Source
AI summary
The present disclosure describes methods of generating three-dimensional skin tissue constructs comprising a basal-to-suprabasal transition.